RFG Advisory LLC Grows Stock Position in Cardinal Health, Inc. $CAH

RFG Advisory LLC lifted its stake in Cardinal Health, Inc. (NYSE:CAH) by 12.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,423 shares of the company’s stock after purchasing an additional 368 shares during the quarter. RFG Advisory LLC’s holdings in Cardinal Health were worth $575,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Greykasell Wealth Strategies Inc. acquired a new stake in shares of Cardinal Health in the first quarter valued at approximately $26,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. GW&K Investment Management LLC increased its holdings in shares of Cardinal Health by 113.4% in the first quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the last quarter. Garde Capital Inc. acquired a new stake in shares of Cardinal Health in the first quarter valued at approximately $52,000. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of Cardinal Health in the first quarter valued at approximately $52,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on CAH. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Evercore ISI cut their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research note on Wednesday, August 13th. Robert W. Baird raised their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 13th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $166.00.

Insiders Place Their Bets

In related news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jason M. Hollar sold 35,901 shares of Cardinal Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the transaction, the chief executive officer owned 200,000 shares of the company’s stock, valued at approximately $30,008,000. This trade represents a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. Insiders own 0.12% of the company’s stock.

Cardinal Health Trading Up 2.0%

Shares of NYSE CAH opened at $156.29 on Friday. Cardinal Health, Inc. has a twelve month low of $106.98 and a twelve month high of $168.44. The stock has a fifty day simple moving average of $151.88 and a 200-day simple moving average of $151.72. The stock has a market capitalization of $37.13 billion, a PE ratio of 24.23, a PEG ratio of 1.30 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. During the same period in the previous year, the firm posted $1.84 earnings per share. The company’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s payout ratio is presently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.